Evaluation of SERS labeling of CD20 on CLL cells using optical microscopy and fluorescence flow cytometry  Christina M. MacLaughlin, BSc, Edward P.K.

Slides:



Advertisements
Similar presentations
Date of download: 5/28/2016 Copyright © 2016 SPIE. All rights reserved. (a) A stack of representative three-dimensional images of 80-nm AuNPs embedded.
Advertisements

Date of download: 5/29/2016 Copyright © 2016 SPIE. All rights reserved. A high-resolution photoacoustic scanner consisting of a doubled YAG laser, an OPO,
Probing for chemotherapy-induced peripheral neuropathy in live dorsal root ganglion neurons with atomic force microscopy  Ngan Pan Bennett Au, BS, Yuqiang.
Mark A. Munger, PharmD, Przemyslaw Radwanski, PharmD, PhD, Greg C
Delia Danila, PhD, Evan Johnson, MS, Patrick Kee, MD, PhD 
Convection-enhanced delivery of nanodiamond drug delivery platforms for intracranial tumor treatment  Guifa Xi, MD, PhD, Erik Robinson, PhD, Barbara Mania-Farnell,
Calcium phosphate-polymer hybrid nanoparticles for enhanced triple negative breast cancer treatment via co-delivery of paclitaxel and miR-221/222 inhibitors 
Quantum dot-based lab-on-a-bead system for multiplexed detection of free and total prostate-specific antigens in clinical human serum samples  Kristina.
From solvent-free microspheres to bioactive gradient scaffolds
Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy  Shengpeng.
Factor H inhibits complement activation induced by liposomal and micellar drugs and the therapeutic antibody rituximab in vitro  Tamás Mészáros, MSc,
Quantum dot interactions and flow effects in angiogenic zebrafish (Danio rerio) vessels and human endothelial cells  Xiao-Yu Jiang, MSc, Christopher D.
Protoporphyrin IX–gold nanoparticle conjugates as an efficient photosensitizer in cervical cancer therapy  Hossein Eshghi, PhD, Ameneh Sazgarnia, MSc,
Near-infrared light-responsive nanoparticles with thermosensitive yolk-shell structure for multimodal imaging and chemo-photothermal therapy of tumor 
Improving performance of nanoscale ultrasound contrast agents using N,N- diethylacrylamide stabilization  Reshani H. Perera, PhD, Hanping Wu, MD, PhD,
Michael T. Jacobsen, Michael Fairhead, Per Fogelstrand, Mark Howarth 
Volume 24, Issue 10, Pages e3 (October 2017)
Volume 129, Issue 5, Pages (November 2005)
Volume 49, Issue 1, Pages (January 2006)
Christopher L. Kepley, PhD, Bridget S. Wilson, PhD, Janet M
Volume 12, Issue 1, Pages (January 2005)
A Single Domain–Based Anti-Her2 Antibody Has Potent Antitumor Activities  Xiaoqiong Wu, Siqi Chen, Limin Lin, Jiayu Liu, Yanlan Wang, Yumei Li, Qing Li,
Specific Recognition of Macroscopic Objects by the Cell Surface: Evidence for a Receptor Density Threshold Revealed by Micrometric Particle Binding Characteristics 
Yalei Chen, Melissa M. Rolls, William O. Hancock  Current Biology 
Richard T. Ethridge, Mark R. Hellmich, Raymond N. DuBois, B.Mark Evers 
Volume 8, Pages (October 2018)
Nanotechnology تقانة الصغائر.
Volume 4, Issue 1, Pages (July 2001)
Surface-Sensitive Raman Spectroscopy of Collagen I Fibrils
Visualization of Synaptic Activity in Hippocampal Slices with FM1-43 Enabled by Fluorescence Quenching  Jason L Pyle, Ege T Kavalali, Sukwoo Choi, Richard.
Christina Kratschmer, Matthew Levy  Molecular Therapy - Nucleic Acids 
Mismatch Receptive Fields in Mouse Visual Cortex
Hyperexpression of epidermal growth factor receptors in granulosa cells from women with polycystic ovary syndrome  Ghanim Almahbobi, Ph.D., Aileen Misajon,
Volume 24, Issue 19, Pages (October 2014)
Volume 96, Issue 6, Pages (March 2009)
Volume 38, Issue 1, Pages (January 2013)
Volume 39, Issue 5, Pages (November 2013)
Volume 38, Issue 6, Pages (June 2013)
Fuqing Wu, David J. Menn, Xiao Wang  Chemistry & Biology 
Topical Vaccination with Functionalized Particles Targeting Dendritic Cells  Renato B. Baleeiro, Karl-Heinz Wiesmüller, Yoran Reiter, Barbara Baude, Lars.
Quantum Dot-Mediated Detection of γ-Aminobutyric Acid Binding Sites on the Surface of Living Pollen Protoplasts in Tobacco  Guanghui Yu, Jiangong Liang,
The Nogo Receptor NgR1 Mediates Infection by Mammalian Reovirus
Vitamin D Enhances ALA-Induced Protoporphyrin IX Production and Photodynamic Cell Death in 3-D Organotypic Cultures of Keratinocytes  Nobuyuki Sato, Brian.
Uptake and presentation of antigen to T cells by primary colonic epithelial cells in normal and diseased states  Grzegorz W. Telega, *,‡, Daniel C. Baumgart,
Volume 14, Issue 10, Pages (October 2007)
Volume 3, Issue 6, Pages (December 2017)
Jennifer J Kohler, Carolyn R Bertozzi  Chemistry & Biology 
Volume 16, Issue 11, Pages (November 2009)
Beena Krishnan, Lila M. Gierasch  Chemistry & Biology 
Volume 20, Issue 5, Pages (December 2005)
Georg B. Keller, Tobias Bonhoeffer, Mark Hübener  Neuron 
Volume 19, Issue 7, Pages (July 2012)
Recombinant human zona pellucida protein C produced in Chinese hamster ovary cells binds to human spermatozoa and inhibits sperm–zona pellucida interaction 
Michael T. Jacobsen, Michael Fairhead, Per Fogelstrand, Mark Howarth 
Tom E. Williams, Shanmugam Nagarajan, Periasamy Selvaraj, Cheng Zhu 
Volume 12, Issue 1, Pages (January 2005)
Volume 75, Issue 10, Pages (May 2009)
Volume 29, Issue 5, Pages (June 2014)
Control of Centriole Length by CPAP and CP110
Volume 13, Issue 2, Pages (February 2006)
A CTLA-4 Antagonizing DNA Aptamer with Antitumor Effect
40nm, but not 750 or 1,500nm, Nanoparticles Enter Epidermal CD1a+ Cells after Transcutaneous Application on Human Skin  Annika Vogt, Behazine Combadiere,
Human alveolar epithelial cells engulf apoptotic eosinophils by means of integrin- and phosphatidylserine receptor-dependent mechanisms: A process upregulated.
Luisa Lunardon, MD, Aimee S. Payne, MD, PhD 
Volume 1, Issue 2, Pages (October 2017)
Volume 84, Issue 6, Pages (June 2003)
Volume 107, Issue 4, Pages (August 2014)
Volume 25, Issue 2, Pages (February 2017)
Volume 105, Issue 2, Pages (July 2013)
Altered Peptide Ligands Induce Delayed CD8-T Cell Receptor Interaction—a Role for CD8 in Distinguishing Antigen Quality  Pia P. Yachi, Jeanette Ampudia,
Presentation transcript:

Evaluation of SERS labeling of CD20 on CLL cells using optical microscopy and fluorescence flow cytometry  Christina M. MacLaughlin, BSc, Edward P.K. Parker, MSc, Gilbert C. Walker, PhD, Chen Wang, MD  Nanomedicine: Nanotechnology, Biology and Medicine  Volume 9, Issue 1, Pages 55-64 (January 2013) DOI: 10.1016/j.nano.2012.04.003 Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 1 (A) Schematic illustration of the preparation of rituximab-conjugated SERS gold nanoparticles (AuNPs). (B) SEM image representative of rituximab–SERS AuNPs. (C) Dynamic light scattering histograms indicate an increase in particle hydrodynamic radius following each surface functionalization step. (D) Visible absorption spectra of SERS AuNPs. Inset: a 2-nm shift in the particle plasmon absorption occurred upon PEGylation, and the absorbance maximum did not shift further following conjugation to rituximab antibodies. Nanomedicine: Nanotechnology, Biology and Medicine 2013 9, 55-64DOI: (10.1016/j.nano.2012.04.003) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 2 TEM images of SERS AuNPs incubated with anti-human Fc 5 nm Au secondary antibodies for identification of rituximab primary antibodies on NP surfaces. (A) Rituximab-conjugated SERS AuNPs. (B) SERS AuNPs with PEG coating only. Nanomedicine: Nanotechnology, Biology and Medicine 2013 9, 55-64DOI: (10.1016/j.nano.2012.04.003) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 3 SERS spectra of cell suspensions in PBS following incubation with SERS AuNPs. (A) SERS intensity from targeted cell samples stained with high (1) and low (2) concentrations of rituximab–SERS AuNPs (5.6 pM and 1.4 pM, respectively), in contrast with negative controls using murine IgG1 nonspecific SERS AuNPs (3) and SERS AuNPs with PEG coating only (4). (B) SERS intensity in competitive binding experiments. Cell samples stained with high concentration of rituximab AuNPs (black); cells prestained with unlabeled rituximab before treatment with high concentration SERS probes (dashed). SERS peak assignments are available in Supplementary Materials. Nanomedicine: Nanotechnology, Biology and Medicine 2013 9, 55-64DOI: (10.1016/j.nano.2012.04.003) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 4 Representative dark-field scattering images of CLL cells labeled with SERS AuNPs (100× magnification). The blue channel has been subtracted from original RGB images, and brightness increased to show cell location. Top row: CLL cells subjected to varying SERS AuNP treatments. (A) High concentration of rituximab-conjugated SERS AuNPs; (B) low concentration of rituximab–SERS AuNPs; (C) nonspecific-isotype IgG1–SERS AuNPs. Bottom row, rituximab blocking: images of CLL cells treated with unconjugated rituximab before corresponding SERS AuNP labeling. (D) High concentration of rituximab-conjugated SERS AuNPs; (E) low concentration of rituximab–SERS AuNPs; (F) nonspecific-isotype IgG1–SERS AuNPs. Details of image processing and raw images are provided in Supplementary Materials. Nanomedicine: Nanotechnology, Biology and Medicine 2013 9, 55-64DOI: (10.1016/j.nano.2012.04.003) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 5 Distribution of the sum of pixel intensities corresponding to cell location in dark-field images. Dashed lines show raw data; Gaussian fits are represented by solid lines. Cells treated with a high concentration of rituximab–SERS AuNPs (black); competitive binding treatment whereby cells were blocked with unlabeled rituximab antibodies before treatment with a high concentration of rituximab–SERS AuNPs (dark gray); cells treated with nonspecific IgG1–SERS probes (light gray). Nanomedicine: Nanotechnology, Biology and Medicine 2013 9, 55-64DOI: (10.1016/j.nano.2012.04.003) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 6 Flow-cytometric assessment of SERS AuNP–rituximab binding. (A) Changes in fluorescence intensity of anti-CD20 FITC antibody in cells prestained with unconjugated rituximab (dashed) or rituximab–SERS AuNPs (solid), in comparison to cells stained directly with antibody to CD20 (gray). No blocking was observed following the prestaining with either (B) unconjugated SERS AuNPs or (C) IgG1–SERS AuNPs. (D) Detection of rituximab–SERS AuNPs by secondary staining with an anti-human IgG (Fc-specific) FITC antibody. Cells prestained with unlabeled rituximab (dashed); rituximab–SERS AuNPs (solid); control cells without primary staining (gray). Nanomedicine: Nanotechnology, Biology and Medicine 2013 9, 55-64DOI: (10.1016/j.nano.2012.04.003) Copyright © 2013 Elsevier Inc. Terms and Conditions

Nanomedicine: Nanotechnology, Biology and Medicine 2013 9, 55-64DOI: (10.1016/j.nano.2012.04.003) Copyright © 2013 Elsevier Inc. Terms and Conditions